INTERNATIONAL PATENT: MOLECULAR PARTNERS AG FILES APPLICATION FOR "THERAPEUTIC COMBINATIONS COMPRISING A MULTI-SPECIFIC T CELL ENGAGER"

GENEVA, Sept. 8 -- MOLECULAR PARTNERS AG (Wagistrasse 148952 Zurich-Schlieren) filed a patent application (PCT/EP2025/054959) for "THERAPEUTIC COMBINATIONS COMPRISING A MULTI-SPECIFIC T CELL ENGAGER" on Feb 25, 2025. With publication no. WO/2025/181039, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEGENNE, Philippe (c/o Wagistrasse 148952 Zurich-Schlieren)

Abstract: The invention relates to combination and combination therapies, particularly for the treatment of a myeloid malignancy, such as acute myeloid leukemia (...